1-4 of 4
Paul Dolin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Disease Burden of Idiopathic and Lymphocytic Hypereosinophilic Syndrome in the United States: Evidence from a Real-World Retrospective Study of De-Identified Electronic Health Records and Insurance Claims

Paul Dolin, Thanai Pongdee, Priya Jain, Jennifer Rowell, Chris Edmonds, James M. Eudicone, Amanda M. Moore, Thomas Peer, Kinwei Arnold Chan, Stephanie Yanjing Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 2316.
https://doi.org/10.1182/blood-2024-194822
Published: 2024
Journal Articles

Health-Related Quality of Life, Work Productivity and Activity Impairment, and Fatigue in Patients with Idiopathic or Lymphocytic Hypereosinophilic Syndrome: A Real-World Survey

Juliana Schwaab, Paul Dolin, Priya Jain, Jennifer Rowell, Chris Edmonds, Josepine Persson, Daniel Mascia, Tia Pennant, Fritha Hennessy, Stephanie Yanjing Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 5075.
https://doi.org/10.1182/blood-2024-194818
Published: 2024
Journal Articles

Dynamic Changes in International Staging System As a Predictor of Survival Outcome in Patients with Advanced Multiple Myeloma

Jin-Liern Hong, PhD, Victoria Crossland, PhD, Aaron Galaznik, PhD, Paul Dolin, DPhil
Journal: Blood
Blood (2018) 132 (Supplement 1): 4438.
https://doi.org/10.1182/blood-2018-99-112134
Published: 2018
Journal Articles

Comparing Bortezomib-Lenalidomide-Dexamethasone (VRd) with Carfilzomib-Lenalidomide-Dexamethasone (KRd) in the Patients with Newly Diagnosed Multiple Myeloma (NDMM) in Two Observational Studies

Bin Li, PhD, Kaili Ren, PhD, Lei Shen, PhD, Peijie Hou, PhD, Zhenqiang Su, PhD, Alessandra Di Bacco, PhD, Jin-Liern Hong, PhD, Aaron Galaznik, PhD, Ajeeta B Dash, PhD, Victoria Crossland, PhD, Paul Dolin, DPhil, Sandor Szalma, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3298.
https://doi.org/10.1182/blood-2018-99-115017
Published: 2018